Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients

With the COVID-19 pandemic causing huge threat to public health and definite treatment modalities and preventive vaccines yet to be arrived at, some of the key indicators of relevance to its prognosis have started emerging. One such independent predictor of outcome has been fasting plasma glucose (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikewaki, Nobunao, Iwasaki, Masaru, Abraham, Samuel J. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575334/
https://www.ncbi.nlm.nih.gov/pubmed/33102263
http://dx.doi.org/10.1007/s40200-020-00664-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575334/
https://www.ncbi.nlm.nih.gov/pubmed/33102263
http://dx.doi.org/10.1007/s40200-020-00664-4

Ejemplares similares